SynthesisFrontiers in immunology2026

Combination therapy with anti-PD-1 antibody, radiotherapy, and tyrosine kinase inhibitor for unresectable primary ectopic hepatocellular carcinoma: a case report with genomic profiling and literature review.

Peng Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.